Pharmaceuticals Japan

Japan Gout Treatment Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Japan Gout Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Japan · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $214.4 Mn Placeholder estimate
Estimate 2025 $233.3 Mn 5.7% of the global market
Projected 2034 $498.4 Mn 113.6% Adds $265.1 Mn over 9 forecast years
CAGR 2025–2034 8.8% Faster than 53% of 180 Pharmaceuticals markets here
Key players 5
  • Japan is 5.72% of the global market.
  • In APAC, the largest is China at $292.5 Mn.
  • Fastest growing: India at 11% a year.
  • Japan ranks 2nd of 10 by size in APAC.

Market size projection

Japan

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$265.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Gout Treatment Market market size by year, Japan
YearMarket sizeChange that yearSince 2025
2024 (estimate) $214.4 Mn — —
2025 (base) $233.3 Mn +$18.9 Mn —
2026 (forecast) $253.8 Mn +$20.5 Mn +8.8%
2027 (forecast) $276.2 Mn +$22.3 Mn +18.4%
2028 (forecast) $300.5 Mn +$24.3 Mn +28.8%
2029 (forecast) $326.9 Mn +$26.4 Mn +40.1%
2030 (forecast) $355.7 Mn +$28.8 Mn +52.5%
2031 (forecast) $387.0 Mn +$31.3 Mn +65.9%
2032 (forecast) $421.1 Mn +$34.1 Mn +80.5%
2033 (forecast) $458.1 Mn +$37.1 Mn +96.4%
2034 (forecast) $498.4 Mn +$40.3 Mn +113.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Japan Gout Treatment Market Analysis at a glance
Market size, 2025$233.3 Mn placeholder estimate
Forecast, 2034$498.4 Mn placeholder estimate
Growth (CAGR), 2025–20348.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDrug class, type and end user (see all)
Key playersHorizon Therapeutics (Amgen), Takeda Pharmaceutical Company Ltd, Novartis AG, Teva Pharmaceutical, Shanton Pharma (see all)
Regulator in JapanPMDASource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
Active clinical trials2 in JapanSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Japan. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Japan Gout Treatment Market Analysis Executive Summary

Gout treatments lower uric acid and control painful flares caused by crystals in the joints.

Key segments of the gout Treatment market include drug class (Xanthine Oxidase Inhibitors, Uricosurics and Colchicine) and type (Acute Gout and Chronic Gout).

Bar chart: Japan Gout Treatment market size, 2024–2034, placeholder estimates. $214.4 Mn in 2024, $233.3 Mn in 2025 and $498.4 Mn in 2034, 8.8% CAGR.
Japan Gout Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Japan Gout Treatment Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the gout Treatment market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the gout Treatment market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the gout Treatment market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Gout Treatment Market in Japan

The gout Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Gout Treatment Market in Japan

Gout Treatment in Japan: rules, payment and research

Drugs are reviewed by the Pharmaceuticals and Medical Devices Agency (PMDA) and approved by the Ministry of Health, Labour and Welfare (MHLW).⁠[1] Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).⁠[2] ClinicalTrials.gov lists 2 studies on Gout Treatment that are recruiting, active or about to start in Japan.⁠[3]

[1] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[2] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Japan. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for gout Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Japan.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Gout Treatment right now, from free public sources.

Clinical trials

2 active trials in Japan

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Crystalys Therapeutics 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Shanton Pharma 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Gout Treatment in context

Japan compared

  • Health spending per person: 3,638 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.65 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 5th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 30.0% of people (2025). World: 10.4% of people (2025). Highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Gout Treatment market in Japan?
Placeholder estimate: about $233.3 Mn in 2025, rising to about $498.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Gout Treatment market in Japan growing?
Placeholder estimate: about 8.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Gout Treatment market report cover?
The report splits the market by drug class (Xanthine Oxidase Inhibitors, Uricosurics, Colchicine, NSAIDs and more), type (Acute Gout, Chronic Gout) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Gout Treatment market?
Key players include Horizon Therapeutics (Amgen), Takeda Pharmaceutical Company Ltd, Novartis AG, Teva Pharmaceutical and Shanton Pharma.
What is driving the Gout Treatment market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the gout Treatment market.
Who regulates Gout Treatment in Japan?
Drugs are reviewed by the Pharmaceuticals and Medical Devices Agency (PMDA) and approved by the Ministry of Health, Labour and Welfare (MHLW). Source: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
How is healthcare paid for in Japan?
Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices). Source: Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
How many clinical trials on Gout Treatment are running in Japan?
2 studies are recruiting, active or about to start in Japan, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Japan. Retrieved 12 Nov 2026.
How much research is published on Gout Treatment?
PubMed lists 135 papers on Gout Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Japan

See all

Related on pain

See the topic